| Financial Year |
March 31 2023 |
| Monetary Funds |
1,127,658,903.27 |
| Held-for-trading Financial Assets |
24,121,347.93 |
| Notes Receivable |
8,560,500.00 |
| Accounts Receivable |
161,736,929.77 |
| Advances to Suppliers |
13,545,513.10 |
| Other Receivables |
7,929,299.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
514,444,464.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
964,080,834.59 |
| Other Current Assets |
121,171,519.51 |
| Total Current Assets |
2,943,249,312.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
18,710,331.06 |
| Fixed Assetes |
272,562,633.98 |
| Under-construction Projects |
2,185,948.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,785,028.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,382,312.72 |
| Other Non-Current Assets |
386,291,386.73 |
| Sub-Total of Non-Current Assets |
743,334,746.37 |
| Total Assets |
3,686,584,058.64 |
| Short-Term Loans |
690,275,645.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
75,505,263.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,192,481.64 |
| Taxes Payable |
60,207,358.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,341,644.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,581,886.63 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
896,510,947.79 |
| Long-term Loans |
-- |
| Bonds Payable |
672,437,417.39 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,038,827.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
692,177,654.59 |
| Total Liabilities |
1,588,688,602.38 |
| Paid-In Capital(Or Share Stock) |
401,799,372.00 |
| Capital Surplus |
345,116,955.63 |
| Surplus Reserve |
157,530,943.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,162,285,908.24 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,097,895,456.26 |
| Owner's Equity（Stockholder's Equity） |
2,097,895,456.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,686,584,058.64 |
